KJP--Thanks for the reply. We have a write-up similar to the QIS one, but not quite ready to share it...have another call with the new CEO next week to continue due diligence.
In terms of 1/3 of new business coming from existing EMR providers, we think this business is mostly being taken from very tiny players who are struggling to achieve scale and are not able to keep up with ongoing regulatory requirements or R&D needs. For a public example, Nightingale Informatix NGH.v, is slowly bleeding out and losing revenue and doctors to QHR. The Accuro product is superior to many of the smaller players (more of a one stop shop), as well, although QHR claims to be at a premium price. I am searching around to nail down subscription price comparisons across the major players.
On the Jonoke acquisition, there is a potential $500,000 earn-out over a period of three years.
Happy to keep the discussion going, I can start a new thread and post more notes soon.
